Skip to content

Alamar Biosciences

US · ALMR #2657 by market cap Listed 2026
27.77 -4.49 -13.92%
Live - 5344 symbols - heartbeat 134s ago · 2026-10-08 08:37
Pre-market 28.89 +4.03%
After-hours 28.50 +2.63%
Overnight 27.90 +0.47%
Market cap
1.93B
P/B
6.16
EPS
-0.54
Reader sentiment Are you bullish or bearish on ALMR?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.1 percentage points.

Institutional ownership

Held by institutions
66.68% -0.15pp
Institutions
107 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

VC/PE Fund42.42%
Mutual Fund16.00%
Individual/Insider10.44%
Hedge Fund7.65%
Government Pension Fund0.30%
Public Company0.16%
Family Office/Trust0.11%
Other22.88%

Top holders as of 2026-06-30

Qiming Weichuang Venture Capital Management (Shanghai) Company Limited 15.27% · 10.59M sh
IIF Management Company LLC 9.17% · 6.36M sh
Zhuhai Sherpa Equity Investment Management Company Limited 6.91% · 4.80M sh
Sands Capital Alternatives, LLC 6.10% · 4.23M sh
Yuling Luo 4.45% · 3.09M sh
Lian Luo 4.29% · 2.98M sh
Samsara BioCapital LLC 3.57% · 2.48M sh
T. Rowe Price Group, Inc. 3.19% · 2.21M sh
ARK Investment Management LLC 1.98% · 1.37M sh
Braidwell LP 1.56% · 1.08M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 23 buys · 13 sells

NameRoleStake
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- 15.27%
Yuling Luo Chairperson & CEO 4.45%
Shiping Chen Founder, COO & Director 1.04%
Timothy White President 0.66%
Nicholas Naclerio Independent Director --
Franklin Witney Independent Director --
Robert Ragusa Director --
IIF Management Company LLC -- --
Justin McAnear Chief Financial Officer --
Rebecca Chambers Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-13 John Brottem General Counsel Other Acquisition +29,000 --
2026-09-13 John Brottem General Counsel Other Derivative Acquisition +85,000 $27.99
2026-08-31 Robert Ragusa Director Other Acquisition +5,686 --
2026-08-31 Robert Ragusa Director Other Derivative Acquisition +25,599 $29.36
2026-04-19 Nicholas Naclerio Independent Director Other Acquisition +5,686 --
2026-04-19 Franklin Witney Independent Director Other Derivative Acquisition +206,781 $0.59–7.60
2026-04-19 Franklin Witney Independent Director Other Derivative Disposition -206,781 $0.59–7.60
2026-04-19 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Other Acquisition +10,594,547 --
2026-04-19 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Derivative Exercise and Sale -10,594,547 --
2026-04-19 Yuling Luo Chairperson & CEO Other Derivative Acquisition +1,817,853 $1.53–17.00
2026-04-19 Yuling Luo Chairperson & CEO Other Acquisition +76,509 --
2026-04-19 Yuling Luo Chairperson & CEO Other Acquisition +3,088,217 --
2026-04-19 Yuling Luo Chairperson & CEO Other Disposition -113,051 --
2026-04-19 Yuling Luo Chairperson & CEO Derivative Exercise and Sale -2,975,166 --
2026-04-19 Yuling Luo Chairperson & CEO Other Derivative Disposition -1,476,662 $1.53–7.60
2026-04-19 Shiping Chen Founder, COO & Director Other Derivative Acquisition +464,241 $3.34–17.00
2026-04-19 Shiping Chen Founder, COO & Director Other Acquisition +37,220 --
2026-04-19 Shiping Chen Founder, COO & Director Other Acquisition +722,885 --
2026-04-19 Shiping Chen Founder, COO & Director Other Disposition -329,521 --
2026-04-19 Shiping Chen Founder, COO & Director Derivative Exercise and Sale -393,364 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:37:42 · For reference only, not investment advice and not tailored to your situation.